Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.

Bibliographic Details
Title: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Authors: Pallocca, Matteo1 (AUTHOR) matteo.pallocca@ifo.it, Molineris, Ivan2,3 (AUTHOR), Berrino, Enrico3,4 (AUTHOR), Marcozzi, Benedetta1 (AUTHOR), Betti, Martina1 (AUTHOR), Levati, Lauretta5 (AUTHOR), D'Atri, Stefania5 (AUTHOR), Menin, Chiara6 (AUTHOR), Madonna, Gabriele7 (AUTHOR), Ghiorzo, Paola8,9 (AUTHOR), Bulgarelli, Jenny10 (AUTHOR), Ferraresi, Virgina11 (AUTHOR), Venesio, Tiziana3 (AUTHOR), Rodolfo, Monica12 (AUTHOR), Rivoltini, Licia12 (AUTHOR), Lanfrancone, Luisa13 (AUTHOR), Ascierto, Paolo Antonio6 (AUTHOR), Mazzarella, Luca14 (AUTHOR), Pelicci, Pier Giuseppe13,15 (AUTHOR), De Maria, Ruggero14 (AUTHOR)
Source: Journal of Translational Medicine. 1/6/2024, Vol. 22 Issue 1, p1-7. 7p.
Subject Terms: *MACHINE learning, *SINGLE nucleotide polymorphisms, *MEDICAL screening, *MELANOMA, *RANDOM forest algorithms, *PROGRESSION-free survival
Abstract: Background: The current therapeutic algorithm for Advanced Stage Melanoma comprises of alternating lines of Targeted and Immuno-therapy, mostly via Immune-Checkpoint blockade. While Comprehensive Genomic Profiling of solid tumours has been approved as a companion diagnostic, still no approved predictive biomarkers are available for Melanoma aside from BRAF mutations and the controversial Tumor Mutational Burden. This study presents the results of a Multi-Centre Observational Clinical Trial of Comprehensive Genomic Profiling on Target and Immuno-therapy treated advanced Melanoma. Methods: 82 samples, collected from 7 Italian Cancer Centres of FFPE-archived Metastatic Melanoma and matched blood were sequenced via a custom-made 184-gene amplicon-based NGS panel. Sequencing and bioinformatics analysis was performed at a central hub. Primary analysis was carried out via the Ion Reporter framework. Secondary analysis and Machine Learning modelling comprising of uni and multivariate, COX/Lasso combination, and Random Forest, was implemented via custom R/Python scripting. Results: The genomics landscape of the ACC-mela cohort is comparable at the somatic level for Single Nucleotide Variants and INDELs aside a few gene targets. All the clinically relevant targets such as BRAF and NRAS have a comparable distribution thus suggesting the value of larger scale sequencing in melanoma. No comparability is reached at the CNV level due to biotechnological biases and cohort numerosity. Tumour Mutational Burden is slightly higher in median for Complete Responders but fails to achieve statistical significance in Kaplan–Meier survival analysis via several thresholding strategies. Mutations on PDGFRB, NOTCH3 and RET were shown to have a positive effect on Immune-checkpoint treatment Overall and Disease-Free Survival, while variants in NOTCH4 were found to be detrimental for both endpoints. Conclusions: The results presented in this study show the value and the challenge of a genomics-driven network trial. The data can be also a valuable resource as a validation cohort for Immunotherapy and Target therapy genomic biomarker research. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Translational Medicine is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=14795876&ISBN=&volume=22&issue=1&date=20240106&spage=1&pages=1-7&title=Journal of Translational Medicine&atitle=Comprehensive%20genomic%20profiling%20on%20metastatic%20Melanoma%3A%20results%20from%20a%20network%20screening%20from%207%20Italian%20Cancer%20Centres.&aulast=Pallocca%2C%20Matteo&id=DOI:10.1186/s12967-023-04776-2
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: a9h
DbLabel: Academic Search Complete
An: 174638794
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Pallocca%2C+Matteo%22">Pallocca, Matteo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> matteo.pallocca@ifo.it</i><br /><searchLink fieldCode="AR" term="%22Molineris%2C+Ivan%22">Molineris, Ivan</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berrino%2C+Enrico%22">Berrino, Enrico</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marcozzi%2C+Benedetta%22">Marcozzi, Benedetta</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Betti%2C+Martina%22">Betti, Martina</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Levati%2C+Lauretta%22">Levati, Lauretta</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22D'Atri%2C+Stefania%22">D'Atri, Stefania</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Menin%2C+Chiara%22">Menin, Chiara</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Madonna%2C+Gabriele%22">Madonna, Gabriele</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ghiorzo%2C+Paola%22">Ghiorzo, Paola</searchLink><relatesTo>8,9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bulgarelli%2C+Jenny%22">Bulgarelli, Jenny</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ferraresi%2C+Virgina%22">Ferraresi, Virgina</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Venesio%2C+Tiziana%22">Venesio, Tiziana</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rodolfo%2C+Monica%22">Rodolfo, Monica</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rivoltini%2C+Licia%22">Rivoltini, Licia</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lanfrancone%2C+Luisa%22">Lanfrancone, Luisa</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ascierto%2C+Paolo+Antonio%22">Ascierto, Paolo Antonio</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mazzarella%2C+Luca%22">Mazzarella, Luca</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pelicci%2C+Pier+Giuseppe%22">Pelicci, Pier Giuseppe</searchLink><relatesTo>13,15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Maria%2C+Ruggero%22">De Maria, Ruggero</searchLink><relatesTo>14</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Translational+Medicine%22">Journal of Translational Medicine</searchLink>. 1/6/2024, Vol. 22 Issue 1, p1-7. 7p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *<searchLink fieldCode="DE" term="%22MACHINE+learning%22">MACHINE learning</searchLink><br />*<searchLink fieldCode="DE" term="%22SINGLE+nucleotide+polymorphisms%22">SINGLE nucleotide polymorphisms</searchLink><br />*<searchLink fieldCode="DE" term="%22MEDICAL+screening%22">MEDICAL screening</searchLink><br />*<searchLink fieldCode="DE" term="%22MELANOMA%22">MELANOMA</searchLink><br />*<searchLink fieldCode="DE" term="%22RANDOM+forest+algorithms%22">RANDOM forest algorithms</searchLink><br />*<searchLink fieldCode="DE" term="%22PROGRESSION-free+survival%22">PROGRESSION-free survival</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: The current therapeutic algorithm for Advanced Stage Melanoma comprises of alternating lines of Targeted and Immuno-therapy, mostly via Immune-Checkpoint blockade. While Comprehensive Genomic Profiling of solid tumours has been approved as a companion diagnostic, still no approved predictive biomarkers are available for Melanoma aside from BRAF mutations and the controversial Tumor Mutational Burden. This study presents the results of a Multi-Centre Observational Clinical Trial of Comprehensive Genomic Profiling on Target and Immuno-therapy treated advanced Melanoma. Methods: 82 samples, collected from 7 Italian Cancer Centres of FFPE-archived Metastatic Melanoma and matched blood were sequenced via a custom-made 184-gene amplicon-based NGS panel. Sequencing and bioinformatics analysis was performed at a central hub. Primary analysis was carried out via the Ion Reporter framework. Secondary analysis and Machine Learning modelling comprising of uni and multivariate, COX/Lasso combination, and Random Forest, was implemented via custom R/Python scripting. Results: The genomics landscape of the ACC-mela cohort is comparable at the somatic level for Single Nucleotide Variants and INDELs aside a few gene targets. All the clinically relevant targets such as BRAF and NRAS have a comparable distribution thus suggesting the value of larger scale sequencing in melanoma. No comparability is reached at the CNV level due to biotechnological biases and cohort numerosity. Tumour Mutational Burden is slightly higher in median for Complete Responders but fails to achieve statistical significance in Kaplan–Meier survival analysis via several thresholding strategies. Mutations on PDGFRB, NOTCH3 and RET were shown to have a positive effect on Immune-checkpoint treatment Overall and Disease-Free Survival, while variants in NOTCH4 were found to be detrimental for both endpoints. Conclusions: The results presented in this study show the value and the challenge of a genomics-driven network trial. The data can be also a valuable resource as a validation cohort for Immunotherapy and Target therapy genomic biomarker research. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Journal of Translational Medicine is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=174638794
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12967-023-04776-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 1
    Subjects:
      – SubjectFull: MACHINE learning
        Type: general
      – SubjectFull: SINGLE nucleotide polymorphisms
        Type: general
      – SubjectFull: MEDICAL screening
        Type: general
      – SubjectFull: MELANOMA
        Type: general
      – SubjectFull: RANDOM forest algorithms
        Type: general
      – SubjectFull: PROGRESSION-free survival
        Type: general
    Titles:
      – TitleFull: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pallocca, Matteo
      – PersonEntity:
          Name:
            NameFull: Molineris, Ivan
      – PersonEntity:
          Name:
            NameFull: Berrino, Enrico
      – PersonEntity:
          Name:
            NameFull: Marcozzi, Benedetta
      – PersonEntity:
          Name:
            NameFull: Betti, Martina
      – PersonEntity:
          Name:
            NameFull: Levati, Lauretta
      – PersonEntity:
          Name:
            NameFull: D'Atri, Stefania
      – PersonEntity:
          Name:
            NameFull: Menin, Chiara
      – PersonEntity:
          Name:
            NameFull: Madonna, Gabriele
      – PersonEntity:
          Name:
            NameFull: Ghiorzo, Paola
      – PersonEntity:
          Name:
            NameFull: Bulgarelli, Jenny
      – PersonEntity:
          Name:
            NameFull: Ferraresi, Virgina
      – PersonEntity:
          Name:
            NameFull: Venesio, Tiziana
      – PersonEntity:
          Name:
            NameFull: Rodolfo, Monica
      – PersonEntity:
          Name:
            NameFull: Rivoltini, Licia
      – PersonEntity:
          Name:
            NameFull: Lanfrancone, Luisa
      – PersonEntity:
          Name:
            NameFull: Ascierto, Paolo Antonio
      – PersonEntity:
          Name:
            NameFull: Mazzarella, Luca
      – PersonEntity:
          Name:
            NameFull: Pelicci, Pier Giuseppe
      – PersonEntity:
          Name:
            NameFull: De Maria, Ruggero
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 01
              Text: 1/6/2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 14795876
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of Translational Medicine
              Type: main
ResultId 1